United Therapeutics Corp (UTHR):企業の財務・戦略的SWOT分析

◆英語タイトル:United Therapeutics Corp (UTHR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH1845FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

United Therapeutics Corp (UTHR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

United Therapeutics Corp (United Therapeutics) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company’s products consist of prostacyclin analogues including Remodulin (treprostinil) injection; Tyvaso (treprostinil) inhalation solution; and Orenitram (treprostinil). Adcirca (tadalafil) is a phosphodiesterase type 5 (PDE-5) inhibitor and Unituxin (dinutuximab) is used for monoclonal antibody for oncologic applications are the other products. Its product candidates include monoclonal antibodies (mAbs), glycobiology antiviral agents and cell-based therapies. The company also develops engineered lungs for transplantation in pre-clinical stage. It manufactures its products in its facility in Silver Spring, Maryland. It markets its products across the US and worldwide primarily Europe, South America and Israel. United Therapeutics is headquartered in Silver Spring, Maryland, the US.

United Therapeutics Corp Key Recent Developments

Apr 26,2021: United Therapeutics Corporation To Report First Quarter 2021 Financial Results Before The Market Opens On Wednesday, May 5, 2021
Mar 09,2021: United Therapeutics Corporation To Present At The Oppenheimer 31st Annual Healthcare Conference
Feb 24,2021: United Therapeutics reports fourth quarter and full year 2020 financial results
Feb 17,2021: United Therapeutics To Report Fourth Quarter And Full Year 2020 Financial Results Before The Market Opens On Wednesday, February 24, 2021
Oct 28,2020: United Therapeutics reports third quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
United Therapeutics Corp – Key Facts
United Therapeutics Corp – Key Employees
United Therapeutics Corp – Key Employee Biographies
United Therapeutics Corp – Major Products and Services
United Therapeutics Corp – History
United Therapeutics Corp – Company Statement
United Therapeutics Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
United Therapeutics Corp – Business Description
Product Category: Adcirca (tadalafil)
Overview
Performance
Product Category: Orenitram (treprostinil)
Overview
Performance
Product Category: Remodulin (treprostinil)
Overview
Performance
Product Category: Tyvaso (treprostinil)
Overview
Performance
Product Category: Unituxin (dinutuximab)
Overview
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
United Therapeutics Corp – Corporate Strategy
United Therapeutics Corp – SWOT Analysis
SWOT Analysis – Overview
United Therapeutics Corp – Strengths
United Therapeutics Corp – Weaknesses
United Therapeutics Corp – Opportunities
United Therapeutics Corp – Threats
United Therapeutics Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
United Therapeutics Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 26, 2021: United Therapeutics Corporation To Report First Quarter 2021 Financial Results Before The Market Opens On Wednesday, May 5, 2021
Mar 09, 2021: United Therapeutics Corporation To Present At The Oppenheimer 31st Annual Healthcare Conference
Feb 24, 2021: United Therapeutics reports fourth quarter and full year 2020 financial results
Feb 17, 2021: United Therapeutics To Report Fourth Quarter And Full Year 2020 Financial Results Before The Market Opens On Wednesday, February 24, 2021
Oct 28, 2020: United Therapeutics reports third quarter 2020 financial results
Oct 21, 2020: United Therapeutics to Report Third Quarter 2020 Financial Results Before The Market Opens On Wednesday, October 28, 2020
Sep 11, 2020: United Therapeutics appoints Linda Maxwell to its Board of Directors
Jul 29, 2020: United Therapeutics reports second quarter 2020 financial results
Apr 29, 2020: United Therapeutics reports first quarter 2020 financial results
Feb 26, 2020: United Therapeutics reports fourth quarter and full year 2019 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
United Therapeutics Corp, Key Facts
United Therapeutics Corp, Key Employees
United Therapeutics Corp, Key Employee Biographies
United Therapeutics Corp, Major Products and Services
United Therapeutics Corp, History
United Therapeutics Corp, Other Locations
United Therapeutics Corp, Subsidiaries
United Therapeutics Corp, Key Competitors
United Therapeutics Corp, Ratios based on current share price
United Therapeutics Corp, Annual Ratios
United Therapeutics Corp, Annual Ratios (Cont...1)
United Therapeutics Corp, Annual Ratios (Cont...2)
United Therapeutics Corp, Interim Ratios
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
United Therapeutics Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[United Therapeutics Corp (UTHR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Electricite de France SA (EDF):石油・ガス:M&Aディール及び事業提携情報
    Summary Electricite de France S.A. (EDF) is a state-owned integrated energy company that generates, transmits, distributes and sells electricity; supplies natural gas; and offers energy services such as district heating, thermal energy services and other services. The group generates electricity fro …
  • Kuwait Petroleum International Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Kuwait Petroleum International Ltd (KPI), a subsidiary of Kuwait Petroleum Corporation, is a downstream energy company. It carries out refining of crude oil, production and marketing of refined petroleum products. The company operates refinery in Milazzo, Italy, and has retail service statio …
  • Clark Construction Group, LLC:企業の戦略的SWOT分析
    Clark Construction Group, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Wentworth Resources Ltd (WRL):企業の財務・戦略的SWOT分析
    Wentworth Resources Ltd (WRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Yanchang Petroleum International Ltd (346):企業の財務・戦略的SWOT分析
    Yanchang Petroleum International Ltd (346) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Toyota Industries Corporation (6201):企業の財務・戦略的SWOT分析
    Toyota Industries Corporation (6201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Biofrontera AG (B8F):企業の財務・戦略的SWOT分析
    Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Anthem Inc (ANTM):製薬・医療:M&Aディール及び事業提携情報
    Summary Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers managed healthcare related products and administrative services. The company provides various specialty and insurance products and services including radiology benefit management, dental, life and disability …
  • DIC Corporation:企業の戦略・SWOT・財務分析
    DIC Corporation - Strategy, SWOT and Corporate Finance Report Summary DIC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cummins Inc.:企業の戦略・SWOT・財務分析
    Cummins Inc. - Strategy, SWOT and Corporate Finance Report Summary Cummins Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Huntington Memorial Hospital:企業の戦略的SWOT分析
    Huntington Memorial Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Screen Holdings Co., Ltd. (7735):企業の財務・戦略的SWOT分析
    Screen Holdings Co., Ltd. (7735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • SK Chemicals Co Ltd (006120):製薬・医療:M&Aディール及び事業提携情報
    Summary SK Chemicals Co Ltd (SK Chemicals) is a chemical company that provides life sciences products and solutions. The company manufactures polyester and acetate yarns for textile, and industrial uses. Its copolyesters comprise ecozen, skygreen and skypets. SK Chemicals provides high-performance r …
  • Tat Seng Packaging Group Ltd. (T12):企業の戦略的SWOT分析
    Tat Seng Packaging Group Ltd. (T12) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • United Rentals Inc:戦略・SWOT・企業財務分析
    United Rentals Inc - Strategy, SWOT and Corporate Finance Report Summary United Rentals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • M.M.Warburg & Co Kgaa
    M.M.Warburg & Co Kgaa - Strategy, SWOT and Corporate Finance Report Summary M.M.Warburg & Co Kgaa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Memphasys Ltd (MEM)-製薬・医療分野:企業M&A・提携分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a life science company that develops and sells pre-cast electrophoresis gels, separations equipment and consumables, analytical software, and other biological products. The company offers gels which include tris glycine, and tris hepe …
  • Aspyrian Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aspyrian Therapeutics Inc (Aspyrian Therapeutics) is a biotechnology company which develops precision targeted medicines to handle both the primary tumor and systemic disease. Its lead pipeline product, RM-1929, is under development for the treatment of different cancer types, including canc …
  • Rangeland Energy LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Rangeland Energy LLC (Rangeland Energy) is a midstream energy company. The company services include transloading, storing frac sand, moving inbound and outbound crude oil and associated natural gas products. It also provides Rangeland integrated oil systems, which is a multipart crude and sa …
  • Bakkavor Group Limited:企業の戦略・SWOT・財務情報
    Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report Summary Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆